Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advanced Bionics enters SCS market with Precision

This article was originally published in The Gray Sheet

Executive Summary

PMA approval of the rechargeable spinal cord stimulation (SCS) implant for chronic pain April 28 marks entry into a $350 mil. U.S. market, the firm says. The PMA was supported by a literature review with safety data from 880 patients and efficacy results from 116 patients. The firm will compete primarily with Advanced Neuromodulation Systems and Medtronic, which offer Genesis and Itrel SCS, respectively. Precision is the first such device to offer rechargeability and "real-time" programming, Advanced Bionics claims...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT020135

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel